Suppr超能文献

微量白蛋白尿与炎症性肠病患者的肠道组织病理学分级相关。

Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease.

作者信息

Mahmud N, McDonald G S, Kelleher D, Weir D G

机构信息

Department of Clinical Medicine, Trinity College, Dublin, Ireland.

出版信息

Gut. 1996 Jan;38(1):99-103. doi: 10.1136/gut.38.1.99.

Abstract

It has previously been shown that microalbuminuria is a useful disease activity marker for inflammatory bowel disease (IBD). Microalbuminuria correlates strongly with the markers of clinical and laboratory disease activity such as erythrocyte sedimentation rate (ESR), and C reactive protein (CRP). The aim of this study was to discover if microalbuminuria accurately reflects the intestinal inflammation by correlating it with intestinal inflammation using a standard histopathological grading system in patients with ulcerative colitis and Crohn's colitis. Forty two patients with IBD who had undergone endoscopic examination of the entire colon for the assessment of severity and extent of the disease (Crohn's colitis (n = 21), ulcerative colitis (n = 21)) were recruited to the study. Patients with small bowel Crohn's disease were not studied. Twenty four patients had left sided colonic disease and 18 patients had extensive colonic disease. Each patient's colonic biopsy specimens were scored blindly by a histopathologist and a composite score was compiled on the basis of the severity of changes in the enterocytes and crypts and the cellularity of the lamina propria. A clinical disease activity was obtained using the simple index of Harvey and Bradshaw. Microalbuminuria was measured in all patients by an immunoturbiditimetric method. ESR and CRP were also measured, as indicators of acute phase response in the same patients. It was found that patients with active IBD had higher concentrations of microalbuminuria compared with those patients in remission (median 222 micrograms/min (range 40-686 micrograms/min) v median 96 micrograms/min (range 30-376 micrograms/min); p < 0.001)). Significantly higher concentrations of microalbuminuria were also detected in patients with extensive colonic IBD compared with those patients with left sided disease (median 297 micrograms/min (range 132-686 micrograms/min) v median 101 micrograms/min (range 30-433 micrograms/min); p < 0.001)). A strong positive correlation was seen between microalbuminuria and intestinal histopathological score in IBD patient groups with left sided colitis (r = 0.77; p < 0.001) and extensive disease (r = 0.71; p < 0.01). The standard histopathological grading system correlated with the clinical disease activity (r = 0.64; p < 0.005) and CRP (r = 0.62; p < 0.02), however, it did not correlate with ESR. In conclusion, the strong correlation of microalbuminuria with a standard intestinal histopathological grading system suggests that microalbuminuria accurately reflects the severity of colonic inflammation in patients with Crohn's colitis and ulcerative colitis.

摘要

此前已有研究表明,微量白蛋白尿是炎症性肠病(IBD)的一种有用的疾病活动标志物。微量白蛋白尿与临床和实验室疾病活动指标密切相关,如红细胞沉降率(ESR)和C反应蛋白(CRP)。本研究的目的是通过在溃疡性结肠炎和克罗恩氏结肠炎患者中使用标准组织病理学分级系统将微量白蛋白尿与肠道炎症相关联,来探究微量白蛋白尿是否能准确反映肠道炎症。42例因评估疾病严重程度和范围而接受全结肠内镜检查的IBD患者(克罗恩氏结肠炎(n = 21),溃疡性结肠炎(n = 21))被纳入研究。小肠克罗恩病患者未纳入研究。24例患者患有左侧结肠疾病,18例患者患有广泛性结肠疾病。每位患者的结肠活检标本由一名组织病理学家进行盲法评分,并根据肠上皮细胞和隐窝变化的严重程度以及固有层的细胞密度编制综合评分。使用Harvey和Bradshaw简单指数获得临床疾病活动度。所有患者均采用免疫比浊法测量微量白蛋白尿。还测量了同一患者的ESR和CRP,作为急性期反应指标。结果发现,与缓解期患者相比,活动期IBD患者的微量白蛋白尿浓度更高(中位数222微克/分钟(范围40 - 686微克/分钟)对中位数96微克/分钟(范围30 - 376微克/分钟);p < 0.001)。与左侧疾病患者相比,广泛性结肠IBD患者的微量白蛋白尿浓度也显著更高(中位数297微克/分钟(范围132 - 686微克/分钟)对中位数101微克/分钟(范围30 - 433微克/分钟);p < 0.001)。在左侧结肠炎的IBD患者组(r = 0.77;p < 0.001)和广泛性疾病患者组(r = 0.71;p < 0.01)中,微量白蛋白尿与肠道组织病理学评分之间存在强正相关。标准组织病理学分级系统与临床疾病活动度(r = 0.64;p < 0.005)和CRP(r = 0.62;p < 0.02)相关,然而,它与ESR不相关。总之,微量白蛋白尿与标准肠道组织病理学分级系统的强相关性表明,微量白蛋白尿能准确反映克罗恩氏结肠炎和溃疡性结肠炎患者结肠炎症的严重程度。

相似文献

2
Microalbuminuria in inflammatory bowel disease.
Gut. 1994 Nov;35(11):1599-604. doi: 10.1136/gut.35.11.1599.
3
Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
World J Gastroenterol. 2017 Dec 14;23(46):8235-8247. doi: 10.3748/wjg.v23.i46.8235.
6
Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Am J Gastroenterol. 2002 Dec;97(12):3071-7. doi: 10.1111/j.1572-0241.2002.07028.x.
8
Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
Eur J Pediatr. 2016 Oct;175(10):1335-42. doi: 10.1007/s00431-016-2762-2. Epub 2016 Aug 29.

引用本文的文献

1
Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the Future.
J Gastroenterol Hepatol. 2025 Apr;40(4):808-820. doi: 10.1111/jgh.16895. Epub 2025 Feb 2.
2
Prevalence of Renal Stones Among Patients With Inflammatory Bowel Disease in Saudi Arabia.
Cureus. 2021 Jun 21;13(6):e15787. doi: 10.7759/cureus.15787. eCollection 2021 Jun.
3
Relationship between Microalbuminuria and Disease Activity in Patients with Ulcerative Colitis.
Middle East J Dig Dis. 2020 Jan;12(1):34-38. doi: 10.15171/mejdd.2020.161.
4
Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2262-2268. doi: 10.1016/j.cgh.2019.10.043. Epub 2019 Nov 1.
5
Histologic scoring indices for evaluation of disease activity in Crohn's disease.
Cochrane Database Syst Rev. 2017 Jul 21;7(7):CD012351. doi: 10.1002/14651858.CD012351.pub2.
6
Histologic scoring indices for evaluation of disease activity in ulcerative colitis.
Cochrane Database Syst Rev. 2017 May 25;5(5):CD011256. doi: 10.1002/14651858.CD011256.pub2.
7
CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis.
Mucosal Immunol. 2016 May;9(3):689-701. doi: 10.1038/mi.2015.93. Epub 2015 Sep 16.
8
Identification and management of albuminuria in the primary care setting.
J Clin Hypertens (Greenwich). 2011 Jun;13(6):438-49. doi: 10.1111/j.1751-7176.2010.00424.x. Epub 2011 Feb 1.
10
No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases.
Int J Colorectal Dis. 2003 Sep;18(5):406-12. doi: 10.1007/s00384-002-0467-7. Epub 2003 Feb 8.

本文引用的文献

1
Disruption of sulphated glycosaminoglycans in intestinal inflammation.
Lancet. 1993 Mar 20;341(8847):711-4. doi: 10.1016/0140-6736(93)90485-y.
2
Microalbuminuria in inflammatory bowel disease.
Gut. 1994 Nov;35(11):1599-604. doi: 10.1136/gut.35.11.1599.
10
A simple index of Crohn's-disease activity.
Lancet. 1980 Mar 8;1(8167):514. doi: 10.1016/s0140-6736(80)92767-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验